Pharmaids Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported net loss was INR 7.06 million compared to net income of INR 0.142 million a year ago. Basic loss per share from continuing operations was INR 0.54 compared to basic earnings per share from continuing operations of INR 0.01 a year ago.
For the nine months, net loss was INR 13.94 million compared to net income of INR 0.971 million a year ago. Basic loss per share from continuing operations was INR 1.07 compared to basic earnings per share from continuing operations of INR 0.09 a year ago.